Amphotericin B cholesteryl sulfate: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Amphotericin B cholesteryl sulfate | {{Amphotericin B cholesteryl sulfate}} | ||
'''''For patient information, click <u>[[Amphotericin B cholesteryl sulfate complex (patient information)|here]]</u>'''''. | '''''For patient information, click <u>[[Amphotericin B cholesteryl sulfate complex (patient information)|here]]</u>'''''. | ||
Revision as of 03:14, 10 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Category
Antifungal agent(parenteral)
US Brand Names
Amphotec®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
Binds to ergosterol altering cell membrane permeability in susceptible fungi and causing leakage of cell components with subsequent cell death.